Critical appraisal:Mukai M, Oida Y, Tajima T, Kishima K, Ninomiya H, Sato S, et al 2006 2
From Cancer Guidelines Wiki
Risk of bias assessment: cohort study
Subject selection
"New technology" group
- Selected group
Comparison group
- Selected group
Comparability of groups on demographic characteristics and clinical features
- Not comparable and not adjusted for differences
Measurement of outcomes
Same method of measurement used across comparison groups
- Yes
Completeness of follow-up
Was follow-up complete and were all patients included in the analysis?
- No or not described
Overall risk of bias
High risk of bias | Additional comments: Please replace this text and include any additional comments in regards to your risk of bias rating |
Comments
- Article
- Mukai M, Oida Y, Tajima T, Kishima K, Ninomiya H, Sato S, et al. Alternating hepatic arterial infusion and systemic chemotherapy for stage IV colorectal cancer with synchronous liver metastasis. Oncol Rep 2006 Oct;16(4):865-70 Available from: http://www.ncbi.nlm.nih.gov/pubmed/16969507.
- Assigned to
- User:Verity.chadwick
- Topic area
- Guidelines:Colorectal cancer
- Clinical question
Section below only relevant for Cancer Council Project Officer
"New technology" group - 1) an age of <75 years, 2) a performance status of 0 or 1 (Japan Clinical Oncology Group; JCOG), and 3) complete medical records and follow-up data on recurrence and survival.